# A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects

> **NCT03168984** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma S.P.R.L.** · enrollment: 48 (actual)

## Conditions studied

- Healthy Japanese and Caucasian Subjects

## Interventions

- **DRUG:** UCB0942
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03168984
- **Lead sponsor:** UCB Biopharma S.P.R.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-05
- **Primary completion:** 2017-08-14
- **Final completion:** 2017-08-14
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168984, "A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03168984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*